These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12394781)

  • 1. HIV and drug misuse in the Edinburgh cohort.
    Bell JE; Arango JC; Robertson R; Brettle RP; Leen C; Simmonds P
    J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S35-42. PubMed ID: 12394781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.
    Bell JE; Brettle RP; Chiswick A; Simmonds P
    Brain; 1998 Nov; 121 ( Pt 11)():2043-52. PubMed ID: 9827765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropathology of adult HIV infection.
    Bell JE
    Rev Neurol (Paris); 1998 Dec; 154(12):816-29. PubMed ID: 9932303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?
    Anthony IC; Ramage SN; Carnie FW; Simmonds P; Bell JE
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):325-38. PubMed ID: 15885069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients.
    Bell JE; Donaldson YK; Lowrie S; McKenzie CA; Elton RA; Chiswick A; Brettle RP; Ironside JW; Simmonds P
    AIDS; 1996 May; 10(5):493-9. PubMed ID: 8724040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.
    Dallasta LM; Pisarov LA; Esplen JE; Werley JV; Moses AV; Nelson JA; Achim CL
    Am J Pathol; 1999 Dec; 155(6):1915-27. PubMed ID: 10595922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases.
    Xing HQ; Hayakawa H; Izumo K; Kubota R; Gelpi E; Budka H; Izumo S
    Neuropathology; 2009 Aug; 29(4):433-42. PubMed ID: 19170891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.
    Persidsky Y; Buttini M; Limoges J; Bock P; Gendelman HE
    J Neurovirol; 1997 Dec; 3(6):401-16. PubMed ID: 9475112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does drug abuse influence the microglial response in AIDS and HIV encephalitis?
    Arango JC; Simmonds P; Brettle RP; Bell JE
    AIDS; 2004 Jan; 18 Suppl 1():S69-74. PubMed ID: 15075500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.
    Smith DB; Simmonds P; Bell JE
    J Neurovirol; 2014 Feb; 20(1):28-38. PubMed ID: 24420447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of opiate addiction on neuroinflammation in HIV.
    Byrd D; Murray J; Safdieh G; Morgello S
    J Neurovirol; 2012 Oct; 18(5):364-73. PubMed ID: 22797933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated brain pathology in the United Kingdom: an epidemiological study.
    Davies J; Everall IP; Weich S; McLaughlin J; Scaravilli F; Lantos PL
    AIDS; 1997 Jul; 11(9):1145-50. PubMed ID: 9233462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune control model for viral replication in the CNS during presymptomatic HIV infection.
    McCrossan M; Marsden M; Carnie FW; Minnis S; Hansoti B; Anthony IC; Brettle RP; Bell JE; Simmonds P
    Brain; 2006 Feb; 129(Pt 2):503-16. PubMed ID: 16317019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of CNS HIV burden and its association with neurologic damage.
    Wiley CA; Masliah E; Achim CL
    Adv Neuroimmunol; 1994; 4(3):319-25. PubMed ID: 7874400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 co/super-infection in intravenous drug users.
    Yerly S; Jost S; Monnat M; Telenti A; Cavassini M; Chave JP; Kaiser L; Burgisser P; Perrin L;
    AIDS; 2004 Jul; 18(10):1413-21. PubMed ID: 15199317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis.
    Potula R; Haorah J; Knipe B; Leibhart J; Chrastil J; Heilman D; Dou H; Reddy R; Ghorpade A; Persidsky Y
    Am J Pathol; 2006 Apr; 168(4):1335-44. PubMed ID: 16565506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal apoptosis in human immunodeficiency virus infection.
    Gray F; Adle-Biassette H; Brion F; Ereau T; le Maner I; Levy V; Corcket G
    J Neurovirol; 2000 May; 6 Suppl 1():S38-43. PubMed ID: 10871764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis.
    Zhao ML; Kim MO; Morgello S; Lee SC
    J Neuroimmunol; 2001 Apr; 115(1-2):182-91. PubMed ID: 11282169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus encephalitis in SCID mice.
    Persidsky Y; Limoges J; McComb R; Bock P; Baldwin T; Tyor W; Patil A; Nottet HS; Epstein L; Gelbard H; Flanagan E; Reinhard J; Pirruccello SJ; Gendelman HE
    Am J Pathol; 1996 Sep; 149(3):1027-53. PubMed ID: 8780406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
    Des Jarlais DC; Vanichseni S; Marmor M; Buavirat A; Titus S; Raktham S; Friedmann P; Kitayaporn D; Wolfe H; Friedman SR; Mastro TD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):393-9. PubMed ID: 9420319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.